Silver Book Fact

Direct thrombin inhibitor reduced relative risk of venous thromboembolism

An investigational direct thrombin inhibitor reduced relative risk of venous thromboembolism after total hip replacement surgery by 65.7%—compared to a currently available treatment.

Fuji T, Fujita S, Kawai Y, Nakamura M, et al. Efficacy and Safety of Edoxaban Verus Enoxaparin for the Prevention of Venous Thrombembolism Following Total Hip Arthroplasty: STARS J-V Trial. Orlando, Florida: American Society of Hematology,2010 Annual Meeting; 2015. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534125/pdf/12959_2015_Article_57.pdf

Reference

Title
Efficacy and Safety of Edoxaban Verus Enoxaparin for the Prevention of Venous Thrombembolism Following Total Hip Arthroplasty: STARS J-V Trial
Publisher
American Society of Hematology,2010 Annual Meeting
Publication Date
2015
Authors
Fuji T, Fujita S, Kawai Y, Nakamura M, et al.
Volume & Issue
Volume 13, Issue 27
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • “Over the past thirty-five years, U.S. age-adjusted mortality from cardiovascular disease declined 50 percent. This marked reduction reflects advances in the prevention, diagnosis, and treatment of common cardiovascular conditions.”  
  • Surgical Aortic Valve Replacements in 2010
    In 2010, ~67,500 surgical aortic valve replacements (SAVR) were performed in the U.S.  
  • Cardiovascular disease death rates
    Cardiovascular disease accounts for nearly 801,000 deaths in the US, or about 1 of every 3 deaths in the US.  
  • Without antihypertensive drug therapy, there would have been about 572,000 more hospital discharges for stroke in 2002 and 261,000 more discharges for myocardial infarction.  
  • Medicines Produce Valuable Health Gains for Heart Attack Patients